0.50
price up icon1.83%   0.009
pre-market  Pre-market:  .50  
loading

Bolt Biotherapeutics Inc Stock (BOLT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
152.47%
5.274
2.089 2.528 1.433 1.826
Operating Expenses
2.34%
22.37
21.86 20.71 21.27 20.24
Benefits Costs and Expenses
19.54%
16.09
19.99 - - 18.81
Costs And Expenses
19.54%
16.09
19.99 20.71 21.27 18.81
Operating Income/Loss
13.53%
-17.09
-19.77 -18.18 -19.83 -18.41
Nonoperating Income/Loss
237.14%
6.281
1.863 1.926 1.775 1.435
Income/Loss From Continuing Operations Before Tax
39.61%
-10.81
-17.90 2.528 1.433 -16.98
Income/Loss From Continuing Operations After Tax
39.61%
-10.81
-17.90 -16.26 -18.06 -16.98
Net Income/Loss
39.61%
-10.81
-17.90 -16.26 -18.06 -16.98
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
87,061%
38.07
0.0437 37.87 37.75 37.68
Diluted Average Shares
87,061%
38.07
0.0437 37.87 37.75 37.68
Basic Earnings Per Share
40.43%
-0.28
-0.47 -0.43 -0.48 -0.45
Diluted Earnings Per Share
40.43%
-0.28
-0.47 -0.43 -0.48 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):